Core Viewpoint - Altria Group's stock has recently declined due to disappointing earnings, but it remains a potential buy for long-term investors focused on dividend growth [2][3]. Stock Performance - As of November 17, 2025, Altria's stock (MO) was trading at approximately $58, down from around $67 in early October, primarily due to a 1.7% revenue drop in Q3 and lower Marlboro shipments [3][4]. - The stock has shown some recovery from a recent low of $56, with current prices consolidating around $58, attracting interest from income investors [4]. Dividend History - Altria has increased its dividend for 56 consecutive years, making it part of the elite Dividend Kings list, which includes companies that have raised dividends for 50 years or more [5]. - The company currently offers a forward dividend yield of 7.3%, appealing to younger income investors with longer investment horizons [6]. Valuation Metrics - Altria's price-to-earnings ratio stands at 12.6, indicating that the stock is relatively cheap compared to its earnings [7]. - Despite a decline in annual revenue from $26 billion in 2020 to $24 billion in 2024, the company's bottom line has increased by 144%, from $4.5 billion to $11 billion during the same period [9]. Dividend Payout Ratio - The company's dividend payout ratio is around 76%, which is considered high and may limit reinvestment opportunities in the business [10]. Analyst Consensus - A consensus among 15 analysts rates Altria's stock as a "hold," with a high target price of $72, suggesting a potential upside of 24% over the next 12 months [11]. - Overall, Altria presents a high yield, low valuation, and a strong track record of delivering shareholder value, making it a potential entry point for long-term dividend growth investors [11].

Group 1 - The article discusses the expertise of Sensor Unlimited, who has a PhD in financial economics and has been covering the mortgage market, commercial market, and banking industry for the past decade [2] - Sensor Unlimited focuses on asset allocation and ETFs related to the overall market, bonds, banking and financial sectors, and housing markets [2] - The investing group Envision Early Retirement, led by Sensor Unlimited, offers solutions for generating high income and growth with isolated risks through dynamic asset allocation [2] Group 2 - Envision Early Retirement features two model portfolios: one for short-term survival/withdrawal and another for aggressive long-term growth [2] - The group provides direct access via chat for discussing ideas, monthly updates on holdings, tax discussions, and ticker critiques upon request [2]

Core Insights - Altria Group, Inc. is at a critical juncture as nicotine pouches capture 55.7% of the U.S. oral tobacco market, marking an 11.1-point year-over-year increase, which is altering market dynamics [1][8] - The company faces challenges in maintaining its market share in the rapidly growing oral segment, with its on! brand holding an 8.7% share of the total U.S. oral tobacco category and a reduced 15.6% share in the nicotine pouch segment, down 4.1 points due to competitive promotional activities [1][8] Market Dynamics - Competitor promotions have led to a 7% decrease in average retail prices for nicotine pouches nationally, with some major retail chains experiencing price drops exceeding 70% [2] - Altria's on! brand saw a retail price increase of approximately 1.5% during the same period, indicating a divergence from the broader category pricing trends [2] - Despite the promotional environment, Altria reported steady retail takeaway for on!, suggesting consistent consumer demand [2] Product Development - To enhance its competitive position, Altria is launching on! PLUS, a next-generation nicotine pouch aimed at improving comfort, nicotine delivery, and flavor satisfaction [3] - The product has been introduced in Florida, Texas, and North Carolina, with early research indicating higher purchase intent compared to several competing brands [3] Competitive Landscape - Philip Morris International Inc. reported a 16.9% increase in global pouch shipments and a 39% growth in U.S. ZYN offtake, supported by extensive commercial activities and investments in capacity [5] - Turning Point Brands, Inc. experienced a remarkable 627.6% year-over-year growth in modern oral segment net sales, reaching $36.7 million, which now constitutes nearly 30.8% of its total revenues [6] Financial Performance - Altria's shares have declined by 9.8% over the past month, contrasting with a 1.8% decline in the industry [7] - The company trades at a forward price-to-earnings ratio of 10.47X, lower than the industry average of 14.12X [10] - Zacks Consensus Estimates project year-over-year earnings growth of 6.1% for 2025 and 2.5% for 2026 [11]

Core Insights - The article emphasizes the importance of conducting personal in-depth research and due diligence before making investment decisions, highlighting the inherent risks involved in trading [3]. Group 1 - The analysis is intended for informational purposes only and should not be considered as professional investment advice [3]. - There is a clear disclaimer regarding the lack of any stock or derivative positions in the companies mentioned, indicating a neutral stance [2]. - The article expresses the author's personal opinions and does not reflect any business relationships with the companies discussed [2]. Group 2 - Past performance is noted as not being a guarantee of future results, underscoring the unpredictability of investment outcomes [4]. - The article clarifies that no recommendations or advice are provided regarding the suitability of investments for particular investors [4]. - The authors of the analysis include both professional and individual investors, which may affect the perspectives presented [4].

Core Viewpoint - The article emphasizes a personal investment strategy focused on growth and dividend income, aiming for an easy retirement through a portfolio that prioritizes compounding dividend income and growth [1]. Group 1: Investment Strategy - The strategy involves creating a portfolio that generates monthly dividend income, which is enhanced through dividend reinvestment and annual increases [1]. Group 2: Stock Positions - The article mentions a beneficial long position in the shares of specific companies, including MO, VZ, STWD, and OKE, either through stock ownership, options, or other derivatives [1].

Core Insights - Altria Group, Inc. is recognized as one of the 15 Extreme Dividend Stocks to Buy according to hedge funds [1] - UBS has lowered its price target for Altria from $68 to $61 while maintaining a Neutral rating, citing stronger-than-expected cigarette volumes in Q3 [2] - The company is expected to achieve mid-single-digit earnings growth over the next three years, supported by duty drawbacks and disciplined pricing strategies [3] Financial Performance - In Q3 2025, Altria's smokeable products segment experienced an 8.2% decline in domestic cigarette shipment volumes, resulting in revenue of $16.2 billion [4] - The decline in shipment volumes is attributed to ongoing industry challenges and market share losses, although trade inventory movements provided some offset [4] Market Strategy - Altria continues to heavily rely on the US market, where cigarette consumption has been declining [5] - To adapt to market changes, Altria is expanding its presence in next-generation products through its Njoy brand, which includes single-use vapes and pod systems, showing solid growth despite being a smaller segment of the business [5]

Core Insights - Altria Group, Inc. demonstrated resilience in Q3 2025, maintaining profitability despite volume declines in traditional cigarettes through strategic pricing, cost discipline, and investment in smoke-free alternatives [1][6][19] Financial Performance - Adjusted earnings increased by 3.6% year-over-year to $1.45, while net revenues decreased by 3% to $6.07 billion, primarily due to lower revenues in smokeable and oral tobacco segments [6][8] - Adjusted operating companies income (OCI) in the Smokeable Products segment rose by 0.7%, with margins expanding to 64.4% [7][11] Shareholder Returns - Altria increased its quarterly dividend by 3.9% to $1.06 per share, marking the 60th dividend increase in 56 years, and expanded its share repurchase program to $2 billion through 2026 [9][10] Smoke-Free Initiatives - The Oral Tobacco Products segment's adjusted OCI margin improved to 69.2%, despite a 4.6% revenue decline, with the on! nicotine pouch brand achieving a 0.7% increase in shipment volumes [11][12] - The launch of on! PLUS and a partnership with KT&G Corporation aim to enhance Altria's smoke-free product portfolio and explore global opportunities [12][13] Market Position and Valuation - Altria's stock is trading at a forward P/E ratio of 10.53X, significantly lower than the industry average of 14.17X and the S&P 500's average of 23.66X, indicating a potential value opportunity for investors [15][16] Outlook - The near-term outlook for Altria remains cautious but stable, with adjusted earnings guidance narrowed to $5.37-$5.45, reflecting expected growth of 3.5-5% from 2024 [14]

Core Viewpoint - Altria's stock offers a high yield of 7.5% and trades at a low price-to-earnings multiple of 13, raising questions about its future sustainability and growth potential [2][9]. Group 1: Dividend and Financial Performance - Altria is recognized as a Dividend King, having increased its dividend payout for the 60th time in 56 years, indicating a strong history of returning value to shareholders [2]. - For the period ending September 30, Altria's sales declined by 3% to $6.1 billion, while net earnings rose by 4% to $2.4 billion, showcasing resilience despite challenges [3][4]. - The company projects adjusted earnings per share for the full year to be between $5.37 and $5.45, reflecting a year-over-year growth rate of 3.5% to 5% [3]. Group 2: Growth Challenges - Altria's long-term growth outlook remains uncertain, with oral tobacco products contributing only 11% to its revenue and experiencing a 5% decline year-over-year [5][9]. - Revenue has decreased from $21.1 billion in 2021 to $20.4 billion in 2024, indicating a troubling trend in sales performance [6]. - The current payout ratio is less than 80%, which is sustainable for now, but future growth challenges could jeopardize the safety of the dividend [7][10]. Group 3: Market Position and Risks - Altria's fundamentals may appear stable, but the lack of proven long-term growth raises significant risks for investors [9]. - The stock's high dividend yield and low valuation could be misleading, as deteriorating financials may lead to a reassessment of its value and potential dividend cuts [10].

Core Insights - Altria Group, Inc. has formed an alliance with KT&G to explore international opportunities in modern oral nicotine products, aiming to expand its market presence beyond the U.S. [1][9] - The collaboration includes Altria acquiring a stake in Another Snus Factory, enhancing its product offerings in regions with growing demand for complex flavor profiles [2] - The partnership allows Altria to utilize KT&G's global infrastructure and product development expertise while contributing its strengths in commercialization and brand management [3] - The alliance is a strategic move towards expanding Altria's presence in smoke-free categories globally, as the modern oral market is experiencing rapid growth [4] - Successful execution of this partnership is crucial for Altria to strengthen its position in next-generation products and work towards a smoke-free future [5] Competitive Landscape - Philip Morris International Inc. has established itself as a leader in the smoke-free transition, with smoke-free products contributing 41% of its net revenues in Q3 2025, and its nicotine pouch brand ZYN showing 39% growth [6] - Turning Point Brands, Inc. is also experiencing significant growth, with its Modern Oral portfolio representing nearly one-third of sales and revenues rising 31.2% year-over-year to $119 million in Q3 2025 [7] Financial Performance - Altria's shares have declined by 12.8% over the past month, compared to a 4% decline in the industry [8] - Altria trades at a forward price-to-earnings ratio of 10.46X, lower than the industry average of 14.07X [11] - The Zacks Consensus Estimate indicates year-over-year earnings growth of 6.1% for 2025 and 2.5% for 2026 [12]

Market Overview - The overall market has performed well this year, with the S&P 500 still up double digits despite a recent pullback, which is viewed as a healthy sign [1] Analyst Background - The contributing analyst is part of the iREIT+Hoya Capital investment group and focuses on dividend investing in quality blue-chip stocks, BDCs, and REITs, aiming to help lower and middle-class workers build investment portfolios of high-quality, dividend-paying companies [2] Investment Position - The analyst has a beneficial long position in the shares of MO and VZ, indicating a personal investment interest in these companies [3]